Evidence map›Paper›PMID 23506214›Full record

ArticleJournal of the American Chemical Society2013

Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface.

Mary S Golden, Shaun M Cote, Marianna Sayeg, Brandon S Zerbe, Elizabeth A Villar, Dmitri Beglov, Stephen L Sazinsky, Rosina M Georgiadis, Sandor Vajda, Dima Kozakov and 1 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. NEMO (IKKγ) citrullination in microglia promotes neuroinflammation in the post-ischemic brain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Why Some Targets Benefit from beyond Rule of Five Drugs.Journal of medicinal chemistry · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Exploring the structural origins of cryptic sites on proteins.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Review
  18. Article
  19. A Synthetic Loop Replacement Peptide That Blocks Canonical NF-κB Signaling.Angewandte Chemie (International ed. in English) · 2016
    Article
  20. New Frontiers in Druggability.Journal of medicinal chemistry · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mary S GoldenDepartment of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, Massachusetts 02215, USA.
Shaun M Cote
Marianna Sayeg
Brandon S Zerbe
Elizabeth A Villar
Dmitri Beglov
Stephen L Sazinsky
Rosina M Georgiadis
Sandor Vajda
Dima Kozakov
Adrian Whitty
Boston University · US

Funding

Computational mapping of proteins for the binding of ligandsR01GM064700 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI VAJDA, SANDOR · 2003 to 2015
$4.3M
A MULTISTAGE APPROACH TO PROTEIN-PROTEIN DOCKINGR01GM061867 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI VAJDA, SANDOR · 2000 to 2016
$4.0M
Design of Macrocyclic Inhibitors of the NEMO/IKKa/b Protein-Protein InteractionR01GM094551 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI WHITTY, ADRIAN · 2010 to 2013
$1.7M
Refinement Methods for Protein Docking based on Exploring Multi-Dimensional EnergR01GM093147 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KOZAKOV, DMYTRO, PASCHALIDIS, IOANNIS · 2011 to 2014
$1.2M
NIGMS NIH HHS GM064700NIGMS NIH HHS GM094551NIGMS NIH HHS GM61687NIGMS NIH HHS GM93147NIGMS NIH HHS R01 GM061867NIGMS NIH HHS R01 GM064700NIGMS NIH HHS R01 GM093147NIGMS NIH HHS R01 GM094551
6 · The paper itself

Abstract

We report a comprehensive analysis of binding energy hot spots at the protein-protein interaction (PPI) interface between nuclear factor kappa B (NF-κB) essential modulator (NEMO) and IκB kinase subunit β (IKKβ), an interaction that is critical for NF-κB pathway signaling, using experimental alanine scanning mutagenesis and also the FTMap method for computational fragment screening. The experimental results confirm that the previously identified NEMO binding domain (NBD) region of IKKβ contains the highest concentration of hot-spot residues, the strongest of which are W739, W741, and L742 (ΔΔG = 4.3, 3.5, and 3.2 kcal/mol, respectively). The region occupied by these residues defines a potentially druggable binding site on NEMO that extends for ~16 Å to additionally include the regions that bind IKKβ L737 and F734. NBD residues D738 and S740 are also important for binding but do not make direct contact with NEMO, instead likely acting to stabilize the active conformation of surrounding residues. We additionally found two previously unknown hot-spot regions centered on IKKβ residues L708/V709 and L719/I723. The computational approach successfully identified all three hot-spot regions on IKKβ. Moreover, the method was able to accurately quantify the energetic importance of all hot-spot residues involving direct contact with NEMO. Our results provide new information to guide the discovery of small-molecule inhibitors that target the NEMO/IKKβ interaction. They additionally clarify the structural and energetic complementarity between "pocket-forming" and "pocket-occupying" hot-spot residues, and further validate computational fragment mapping as a method for identifying hot spots at PPI interfaces.

Indexed as

AlanineAlgorithmsAmino AcidsAnisotropyComputational BiologyGenetic VectorsI-kappa B KinaseModels, MolecularMutagenesisMutagenesis, Site-DirectedNF-kappa BProtein BindingRecombinant Fusion ProteinsSignal TransductionX-Ray DiffractionAlanineAmino AcidsI-kappa B KinaseIKBKG protein, humanNF-kappa BRecombinant Fusion Proteins

Identifiers

PMID23506214
PMCPMC3680600
OpenAlexW2035775380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.